Your browser doesn't support javascript.
loading
Dentithecamides A-H, Diacylated Zoanthoxanthin Derivatives with PAX3-FOXO1 Inhibitory Activity from the Hydroid Dentitheca habereri.
Jiang, Wei; Tian, Xiangrong; Wang, Dongdong; Bokesch, Heidi R; Thomas, Cheryl L; Woldemichael, Girma M; Gryder, Berkley E; Wei, Jun S; Song, Young K; Chou, Hsien-Chao; Khan, Javed; O'Keefe, Barry R; Gustafson, Kirk R.
Afiliação
  • Jiang W; Marine Science & Technology Institute, College of Environmental Science & Engineering, Yangzhou University, Yangzhou, Jiangsu 225127, People's Republic of China.
  • Tian X; Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States.
  • Wang D; Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States.
  • Bokesch HR; College of Forestry, Northwest A&F University, Yangling 712100, People's Republic of China.
  • Thomas CL; Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States.
  • Woldemichael GM; Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States.
  • Gryder BE; Basic Science Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702-1201, United States.
  • Wei JS; Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States.
  • Song YK; Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702-1201, United States.
  • Chou HC; Basic Science Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702-1201, United States.
  • Khan J; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, United States.
  • O'Keefe BR; Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Case Comprehensive Cancer Center, Cleveland, Ohio 44106, United States.
  • Gustafson KR; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, United States.
J Nat Prod ; 85(5): 1419-1427, 2022 05 27.
Article em En | MEDLINE | ID: mdl-35465663
ABSTRACT
Chemical investigation of the marine hydroid Dentitheca habereri led to the identification of eight new diacylated zoanthoxanthin alkaloids, named dentithecamides A-H (1-8), along with three previously reported analogues, zoamides B-D (9-11). The structures of compounds 1-11 were elucidated by spectroscopic and spectrometric analyses, including IR, HRESIMS, and NMR experiments, and by comparison with literature data. Compounds 1-11 are the first zoanthoxanthin alkaloids to be reported from a hydroid. Dentithecamides A (1) and B (2) along with zoamides B-D (9-11), which all share a conformationally mobile cycloheptadiene core, inhibited PAX3-FOXO1 regulated transcriptional activity and thus provided a structural framework for the potential development of more potent PAX3-FOXO1 inhibitors.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alcaloides / Imidazóis Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alcaloides / Imidazóis Idioma: En Ano de publicação: 2022 Tipo de documento: Article